Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine
MMV Board Member recognized for services to science
Our 17th Call for proposals in now open!
US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria
Doing research on malaria or NTDs? Request the Pathogen Box, free of charge.
added to WHO's Model List of Essential Medicines for Children
for relapse prevention of P. vivax malaria approved by the US FDA
now treated with injectable artesunate in preference to quinine across 6 countries through the MMV-led ISMO project